Ubiquitech Software Corp (OTCMKTS:UBQU) recently provided an update from its subsidiary, HempLife Today and its CEO, James Ballas, regarding the 1Q2017. The company stated that it has continued to add new customers, at an accelerated pace, through its ever growing online marketing platforms. Moreover, HempLife has stated that it would continue with its educational programs, in an effort to create a larger market for its products.
The company also pointed out that its CannazALL brand has some of the finest CBD products, which are derived from hemp. HempLife also claimed that its NanoTech infusion process is capable of adding 200% more hemp plant materials, as compared to its competitors. In addition to this, UBQU is also working on the development of a new logo and a more interactive website for HempLife, which makes navigating through the website and customer education much easier.
During the 1Q2017, HempLife also introduced its Rapid Ship order processing facility, which has been successfully shipping orders to customers, through USPS priority mail, since the start of February. Moreover, super affiliates of the company continue to be an integral part of its product marketing strategy. So far UBQU claims that their partnership has been profitable and strict quality control guidelines have been imposed on these affiliates. With the retails testing of the CannazALL brand completed, the company claims that it is being approached by multiple retailers, of varying sizes. Currently, the management is evaluating these opportunities to ensure that only the ones with the highest profit margins are selected.
Furthermore, the growing exposure received by HempLife has significantly helped Ubiquitech in recording a surge in revenues. The company expects its revenues to be 50% higher than the previous year. It is expected that UBQU would issue a full year guidance, as well, very soon, as it strives to become the preeminent provider of high-quality CBD products, in the US market.
Ubiquitech Software Corp (OTCMKTS:UBQU) declined by 8.33% in the stock market, on a trade volume of 3.23 million, during the March 10 trading session, to close at $0.022 per share.
2017 Most Disruptive Biotech VBIOhttp://www.financialstrend.com
Disruptive biotech VBIO decodes targeted drug delivery for stem cells
Can CBD Oil Get Rid of Chronic Pain?http://www.greenleaf.farm
Pure Colorado Golden CBD Oil Hemp Extracts
Top Stock Analysis At Journal Transcripthttp://www.journaltranscript.com
Early bird alerts on the hottest OTC companies
Enter The $100 Cannabis Markethttp://www.financialstrend.com
VBIO cannabis industry setup for explosive growth
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure